CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild.
Crispr Therapeutics rallied for a second day on Wednesday, adding 9.6 percent to close at $60.08 apiece, tracking the rally in the biotechnology sector and the broader market.
During the session, the biotechnology industry rose by 3.58 percent amid a flurry of developments in the sector. Meanwhile, Wall Street’s main indices all finished in the green territory.
Additionally, investors may have begun repositioning portfolios ahead of the release of second-quarter earnings results. Based on its historical reporting dates, CRISPR Therapeutics AG will announce its financial and operating results in the first week of August.
A laboratory cultivating cells for the development of gene and cell therapies.
In the first quarter of the year, CRISPR Therapeutics AG widened its net loss by 17 percent to $136 million from $116 million previously.
Revenues, however, jumped by 71.6 percent to $865 million from $504 million year-on-year.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
